Soumi Gupta

Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM)

Janet A. Thomas, Harvey L. Levy, Stephen Amato et al. · Molecular Genetics and Metabolism · 2018 · 183 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

Loss of Raltegravir Susceptibility by Human Immunodeficiency Virus Type 1 Is Conferred via Multiple Nonoverlapping Genetic Pathways

Signe Fransen, Soumi Gupta, Robert M. Danovich et al. · Journal of Virology · 2009 · 169 citations · Full text

Life Sciences, Genetics, Infectious Diseases +17

Evolution of Integrase Resistance During Failure of Integrase Inhibitor-Based Antiretroviral Therapy

Hiroyu Hatano, Harry Lampiris, Signe Fransen et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2010 · 74 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials

Soumi Gupta, Kelly Lau, Cary O. Harding et al. · EBioMedicine · 2018 · 72 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Combinations of Mutations in the Connection Domain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Assessing the Impact on Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitor Resistance

Soumi Gupta, Signe Fransen, Ellen E. Paxinos et al. · Antimicrobial Agents and Chemotherapy · 2010 · 49 citations · Full text

Life Sciences, Genetics, Molecular Biology +17